The Rise and Fall of Safer Supply Programs in Canada
Key Highlights
Medicine · Public Health
This Viewpoint article critically examines the trajectory of safer supply programs in Canada, which were designed to provide pharmaceutical-grade medications to individuals using unregulated opioids. The analysis details the factors that led to the implementation of these harm reduction initiatives and the subsequent political and public health pressures that drove their deimplementation. For a nurse and psychologist focused on chronic disease prevention and health behavior, understanding the policy lifecycle of such interventions is essential for designing resilient, evidence-based public health strategies and anticipating barriers to their sustained adoption.
Novelty: 82%
Rigor: 90%
Significance: 88%
Validity: 92%
Clarity: 95%
Update Your Briefing Preferences
Stay curious. Stay informed —
Science Briefing
Your briefing is personalized based on your selected fields, keywords, and research interests.
